Recent Additions To The Stock Portfolio Of Jim Cramer


Jim Cramer hosts CNBC’s Mad Money. Over the years, the former hedge fund manager has developed a cult following. For a long time, Cramer has been positive on emerging technology like cryptocurrency and cloud services. His net worth is estimated to be over $150 million. CNBC has hired Jim Cramer, a seasoned investor, to run its new subscriber-based platform, the CNBC Investor Club. Cramer resigned his job at The Street for the club, a journal he co-founded more than two decades ago. For 14 years, his hedge fund achieved returns of above 20%.

Here is Insider Monkey’s list of the 10 recent additions to the stock portfolio of Jim Cramer. Innovative Industrial Properties, Inc. is a real estate investment trust that focuses in medical marijuana dispensaries. According to the corporation, revenue for the third quarter was $1.35 million higher than expected. It also revealed that it will invest $51 million in a California property. The athletic goods retailer Big 5 Sporting Goods Corporation is based in the United States. The stock’s short interest has risen to a record high of 40%. However, because the shares are currently in a short squeeze, Cramer recommended it as a Buy during the lightning round of his show. In the third quarter, the company’s results topped market expectations. With the Nokia MX Industrial Edge launch, the company has lately entered the cloud industry. It was chosen by the SoftBank Group in Japan to deploy 5G networks in October. T-2, a Slovenian company, has also signed a five-year deal with Nokia to supply 5G equipment. During the Guest Interview segment of Cramer’s show, the shares of Avnet, Inc. was given a Buy recommendation. For the second year in a row, the company, which provides IT solutions, increased its quarterly dividend payout. Tandem Diabetes Care, Inc. is a medical device company. In the third quarter, the company surpassed market expectations for earnings per share and revenue. The stock is expected to rise in the coming months as US regulators approve the sale and development of diabetic devices. For more details, click 10 Recent Additions To The Stock Portfolio Of Jim Cramer.